US Patent Issued to Pfizer on May 27 for "N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors" (Massachusetts, California, Indiana, Connecticut, Rhode Island Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,344, issued on May 27, was assigned to Pfizer Inc. (New York).

"N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors" was invented by Brian Stephen Gerstenberger (Cambridge, Mass.), Andrew Christopher Flick (Carlsbad, Calif.), Daniel Wei-Shung Kung (Salem, Conn.), Vincent Michael Lombardo (Carmel, Ind.), James John Mousseau (Norwich, Conn.), Philippe Marcel Nuhant (Dorchester, Mass.), Ralph Pelton Robinson Jr. (Gales Ferry, Conn.), Daniel Copley Schmitt (Westerly, R.I.), Mark Edward Schnute (Acton, Mass.), Atli Thorarensen (Stow, Mass.), John Isidro Trujillo (Ledyard, Conn.), Rayomand Jal Unwalla (Bedford, Mass.) and Huixian Wu (East Lyme, Conn.)....